Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Up 4,427.0% in May

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 411,143 shares, an increase of 4,427.0% from the May 14th total of 9,082 shares. Currently, 21.8% of the company’s stock are sold short. Based on an average daily trading volume, of 6,750,071 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Arcadia Biosciences presently has an average rating of “Sell”.

Arcadia Biosciences Trading Down 0.5%

NASDAQ RKDA traded down $0.00 during mid-day trading on Tuesday, reaching $0.92. 67,311 shares of the company’s stock traded hands, compared to its average volume of 608,863. Arcadia Biosciences has a 1-year low of $0.80 and a 1-year high of $6.71. The company has a market cap of $1.90 million, a price-to-earnings ratio of -0.16 and a beta of 0.51. The company has a fifty day simple moving average of $1.12 and a 200-day simple moving average of $2.00.

Arcadia Biosciences (NASDAQ:RKDA) last posted its quarterly earnings data on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The company had revenue of $1.10 million for the quarter, compared to the consensus estimate of $1.60 million.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.